45 CFR § 180 compliance
C · 70
This hospital published part of what § 180 requires.
●Machine-readable file published
○Gross / standard charges
○Discounted cash price
●Payer-specific negotiated rates
●Min / max negotiated charges
●Free, public, no login required
Procedures listed
21,792
Insurances with rates
11
CPT / HCPCS codes
19,478
Source MRF
Most expensive procedures (gross)
A9543
$74,694
IBRITUMOMAB TIUXETAN FOR Y-90 3.2 MG/2ML IV KIT
Gross
$93,368
J0223
$73,503
GIVOSIRAN SODIUM 189 MG/ML SC SOLN
Gross
$91,879
J9347
$70,043
TREMELIMUMAB-ACTL 300 MG/15ML IV SOLN
Gross
$87,554
J7352
$68,120
AFAMELANOTIDE ACETATE 16 MG SC IMPL
Gross
$85,150
J9228
$61,450
IPILIMUMAB 200 MG/40ML IV SOLN
Gross
$76,812
J2507
$52,145
PEGLOTICASE 8 MG/ML IV SOLN
Gross
$65,181
J9266
$46,706
PEGASPARGASE 750 UNIT/ML IJ SOLN
Gross
$58,382
C9766
$45,050
HC REVASC INTRA LITHOTRIP-ATHER
Gross
$56,312
C9765
$45,050
HC REVASC INTRA LITHOTRIP-STENT
Gross
$56,312
C9775
$45,050
HC REVASC LITH-STEN-ATH TIB/PER OPEN OR PERCUTANEOUS TIBIAL/PERONEAL ARTERY(IES); WITH INTRAVASCULAR
Gross
$56,312
C9774
$45,050
HC REVASC LITHOTR-ATHER TIB/PER
Gross
$56,312
C9773
$45,050
HC REVASC LITHOTR-STENT TIB/PER
Gross
$56,312
C9772
$45,050
HC REVASC LITHOTRIP TIBI/PERONE
Gross
$56,312
C9767
$45,050
HC REVASC LITHOTRIP-STENT-ATHER OPEN OR PERCUTANEOUS LOWER EXTREMITY ARTERY(IES) EXCEPT TIBIAL/PERON
Gross
$56,312
J9281
$42,745
MITOMYCIN 80 (2 X 40) MG UL SOLR
Gross
$53,431
J1303
$41,848
RAVULIZUMAB-CWVZ 1100 MG/11ML IV SOLN
Gross
$52,310
J9229
$40,078
INOTUZUMAB OZOGAMICIN 0.9 MG IV SOLR
Gross
$50,098
11285
$39,254
RIBAVIRIN 6 G IN SOLR
Gross
$49,067
33263
$38,108
HC RMVL IMPLTBL DFB PLSE GEN W/RPLCMT PLSE GEN 2 LD
Gross
$47,635
J2350
$36,234
OCRELIZUMAB 300 MG/10ML IV SOLN
Gross
$45,292
37227
$33,639
HC REVASCULARIZE FEM/POP ARTERYANGIOPLASTY/STENT/ATHERECTOMY
Gross
$42,049
J7311
$33,493
FLUOCINOLONE ACETONIDE 0.59 MG IZ IMPL
Gross
$41,866
J9309
$32,792
POLATUZUMAB VEDOTIN-PIIQ 140 MG IV SOLR
Gross
$40,990
J3241
$30,926
TEPROTUMUMAB-TRBW 500 MG IV SOLR
Gross
$38,657
37229
$28,858
HC REVSC OPN/PRQ TIB/PERO W/ATHRC/ANGIOP SM VSL
Gross
$36,073
J9321
$28,630
EPCORITAMAB-BYSP 48 MG/0.8ML SC SOLN
Gross
$35,787
J9334
$28,513
EFGARTIGIMOD ALFA-HYALUR-QVFC 180-2000 MG-UNIT/ML SC SOLN
Gross
$35,641
C9764
$28,263
HC DSTRJ LESION ANUS SIMPLE LASER SURG
Gross
$35,329
36903
$28,263
HC INTRO CATH DIALYSIS CIRCUIT W/TCAT PLMT IV STENT
Gross
$35,329
J9298
$26,870
NIVOLUMAB-RELATLIMAB-RMBW 240-80 MG/20ML IV SOLN
Gross
$33,587
J9029
$26,666
NADOFARAGENE FIRADENOVEC-VNCG 300 BILLION VIRAL PARTICLES/ML IS SUSP
Gross
$33,333
C2616
$26,288
Y-90 MICROSPHERES 3-22 GBQ/VIAL
Gross
$32,860
J9381
$25,668
TEPLIZUMAB-MZWV 2 MG/2ML IV SOLN
Gross
$32,085
J9043
$25,219
CABAZITAXEL 60 MG/6ML IV (AFTER FIRST DILUTION) (WET SOLN VIAL)
Gross
$31,524
J9307
$24,250
PRALATREXATE 40 MG/2ML IV SOLN
Gross
$30,313
37243
$23,860
HC VASCULAR EMBOLIZE/OCCLUDE ORGAN TUMOR INFARCT
Gross
$29,825
J7402
$23,232
MOMETASONE FUROATE 1350 MCG NA IMPL
Gross
$29,040
J9042
$21,918
BRENTUXIMAB VEDOTIN 50 MG IV SOLR
Gross
$27,397
47383
$21,869
HC ABLATION 1/> LIVER TUMOR PERQ CRYOABLATION
Gross
$27,336
J9272
$21,230
DOSTARLIMAB-GXLY 500 MG/10ML IV SOLN
Gross
$26,538
32994
$21,000
HC ABLATION THER 1+ PULM TUMORS PERQ CRYOABLATION
Gross
$26,250
146075
$20,812
GLECAPREVIR-PIBRENTASVIR 100-40 MG PO TABS
Gross
$26,015
J9022
$20,310
ATEZOLIZUMAB 1200 MG/20ML IV SOLN
Gross
$25,387
J9311
$20,294
RITUXIMAB-HYALURONIDASE HUMAN 1400-23400 MG -UT/11.7ML SC SOLN
Gross
$25,367
J1640
$19,782
HEMIN 350 MG IV SOLR
Gross
$24,727
33208
$19,610
HC EP INSER HART PACER XVENOUS ATR/VENTR
Gross
$24,512
37225
$19,423
HC REVASCULARIZE FEM/POP ARTERYANGIOPLASTY/ATHERECTOMY
Gross
$24,279
37226
$19,423
HC REVASCULARIZE FEM/POP ARTERYANGIOPLASTY/STENT
Gross
$24,279
49999
$19,320
HC UNLISTED PROCEDURE ABDOMEN PERITONEUM & OMENTUM
Gross
$24,150
J9119
$19,216
CEMIPLIMAB-RWLC 350 MG/7ML IV SOLN
Gross
$24,020
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| A9543 | IBRITUMOMAB TIUXETAN FOR Y-90 3.2 MG/2ML IV KIT | $93,368 | $74,694 | $60,859 | $93,368 | 27 |
| J0223 | GIVOSIRAN SODIUM 189 MG/ML SC SOLN | $91,879 | $73,503 | $107 | $91,879 | 27 |
| J9347 | TREMELIMUMAB-ACTL 300 MG/15ML IV SOLN | $87,554 | $70,043 | $129 | $87,554 | 27 |
| J7352 | AFAMELANOTIDE ACETATE 16 MG SC IMPL | $85,150 | $68,120 | $3,077 | $85,150 | 27 |
| J9228 | IPILIMUMAB 200 MG/40ML IV SOLN | $76,812 | $61,450 | $168 | $76,812 | 27 |
| J2507 | PEGLOTICASE 8 MG/ML IV SOLN | $65,181 | $52,145 | $3,308 | $65,181 | 27 |
| J9266 | PEGASPARGASE 750 UNIT/ML IJ SOLN | $58,382 | $46,706 | $25,717 | $58,382 | 27 |
| C9766 | HC REVASC INTRA LITHOTRIP-ATHER | $56,312 | $45,050 | $19,232 | $56,312 | 27 |
| C9765 | HC REVASC INTRA LITHOTRIP-STENT | $56,312 | $45,050 | $19,232 | $56,312 | 27 |
| C9775 | HC REVASC LITH-STEN-ATH TIB/PER OPEN OR PERCUTANEOUS TIBIAL/PERONEAL ARTERY(IES); WITH INTRAVASCULAR | $56,312 | $45,050 | $19,232 | $56,312 | 27 |
| C9774 | HC REVASC LITHOTR-ATHER TIB/PER | $56,312 | $45,050 | $19,232 | $56,312 | 27 |
| C9773 | HC REVASC LITHOTR-STENT TIB/PER | $56,312 | $45,050 | $19,232 | $56,312 | 27 |
| C9772 | HC REVASC LITHOTRIP TIBI/PERONE | $56,312 | $45,050 | $12,146 | $56,312 | 27 |
| C9767 | HC REVASC LITHOTRIP-STENT-ATHER OPEN OR PERCUTANEOUS LOWER EXTREMITY ARTERY(IES) EXCEPT TIBIAL/PERON | $56,312 | $45,050 | $19,232 | $56,312 | 27 |
| J9281 | MITOMYCIN 80 (2 X 40) MG UL SOLR | $53,431 | $42,745 | $292 | $53,431 | 27 |
| J1303 | RAVULIZUMAB-CWVZ 1100 MG/11ML IV SOLN | $52,310 | $41,848 | $210 | $52,310 | 27 |
| J9229 | INOTUZUMAB OZOGAMICIN 0.9 MG IV SOLR | $50,098 | $40,078 | $2,488 | $50,098 | 27 |
| 11285 | RIBAVIRIN 6 G IN SOLR | $49,067 | $39,254 | — | — | 0 |
| 33263 | HC RMVL IMPLTBL DFB PLSE GEN W/RPLCMT PLSE GEN 2 LD | $47,635 | $38,108 | $360 | $47,635 | 27 |
| J2350 | OCRELIZUMAB 300 MG/10ML IV SOLN | $45,292 | $36,234 | $56.81 | $45,292 | 27 |
| 37227 | HC REVASCULARIZE FEM/POP ARTERYANGIOPLASTY/STENT/ATHERECTOMY | $42,049 | $33,639 | $10,364 | $42,049 | 27 |
| J7311 | FLUOCINOLONE ACETONIDE 0.59 MG IZ IMPL | $41,866 | $33,493 | $317 | $41,866 | 27 |
| J9309 | POLATUZUMAB VEDOTIN-PIIQ 140 MG IV SOLR | $40,990 | $32,792 | $123 | $40,990 | 27 |
| J3241 | TEPROTUMUMAB-TRBW 500 MG IV SOLR | $38,657 | $30,926 | $327 | $38,657 | 27 |
| 37229 | HC REVSC OPN/PRQ TIB/PERO W/ATHRC/ANGIOP SM VSL | $36,073 | $28,858 | $8,258 | $36,073 | 27 |
| J9321 | EPCORITAMAB-BYSP 48 MG/0.8ML SC SOLN | $35,787 | $28,630 | $51.46 | $35,787 | 27 |
| J9334 | EFGARTIGIMOD ALFA-HYALUR-QVFC 180-2000 MG-UNIT/ML SC SOLN | $35,641 | $28,513 | $31.47 | $35,641 | 27 |
| C9764 | HC DSTRJ LESION ANUS SIMPLE LASER SURG | $35,329 | $28,263 | $12,146 | $35,329 | 27 |
| 36903 | HC INTRO CATH DIALYSIS CIRCUIT W/TCAT PLMT IV STENT | $35,329 | $28,263 | $3,937 | $35,329 | 27 |
| J9298 | NIVOLUMAB-RELATLIMAB-RMBW 240-80 MG/20ML IV SOLN | $33,587 | $26,870 | $181 | $33,587 | 27 |
| J9029 | NADOFARAGENE FIRADENOVEC-VNCG 300 BILLION VIRAL PARTICLES/ML IS SUSP | $33,333 | $26,666 | $23,333 | $70,620 | 27 |
| C2616 | Y-90 MICROSPHERES 3-22 GBQ/VIAL | $32,860 | $26,288 | $18,727 | $32,860 | 27 |
| J9381 | TEPLIZUMAB-MZWV 2 MG/2ML IV SOLN | $32,085 | $25,668 | $35.06 | $32,085 | 27 |
| J9043 | CABAZITAXEL 60 MG/6ML IV (AFTER FIRST DILUTION) (WET SOLN VIAL) | $31,524 | $25,219 | $206 | $31,524 | 27 |
| J9307 | PRALATREXATE 40 MG/2ML IV SOLN | $30,313 | $24,250 | $355 | $30,313 | 27 |
| 37243 | HC VASCULAR EMBOLIZE/OCCLUDE ORGAN TUMOR INFARCT | $29,825 | $23,860 | $7,945 | $29,825 | 27 |
| J7402 | MOMETASONE FUROATE 1350 MCG NA IMPL | $29,040 | $23,232 | $10.78 | $29,040 | 27 |
| J9042 | BRENTUXIMAB VEDOTIN 50 MG IV SOLR | $27,397 | $21,918 | $228 | $27,397 | 27 |
| 47383 | HC ABLATION 1/> LIVER TUMOR PERQ CRYOABLATION | $27,336 | $21,869 | $5,462 | $27,336 | 27 |
| J9272 | DOSTARLIMAB-GXLY 500 MG/10ML IV SOLN | $26,538 | $21,230 | $225 | $26,538 | 27 |
| 32994 | HC ABLATION THER 1+ PULM TUMORS PERQ CRYOABLATION | $26,250 | $21,000 | $4,501 | $26,250 | 27 |
| 146075 | GLECAPREVIR-PIBRENTASVIR 100-40 MG PO TABS | $26,015 | $20,812 | — | — | 0 |
| J9022 | ATEZOLIZUMAB 1200 MG/20ML IV SOLN | $25,387 | $20,310 | $81.93 | $25,387 | 27 |
| J9311 | RITUXIMAB-HYALURONIDASE HUMAN 1400-23400 MG -UT/11.7ML SC SOLN | $25,367 | $20,294 | $35.09 | $25,367 | 27 |
| J1640 | HEMIN 350 MG IV SOLR | $24,727 | $19,782 | $30.59 | $24,727 | 27 |
| 33208 | HC EP INSER HART PACER XVENOUS ATR/VENTR | $24,512 | $19,610 | $481 | $24,512 | 27 |
| 37225 | HC REVASCULARIZE FEM/POP ARTERYANGIOPLASTY/ATHERECTOMY | $24,279 | $19,423 | $8,116 | $24,279 | 27 |
| 37226 | HC REVASCULARIZE FEM/POP ARTERYANGIOPLASTY/STENT | $24,279 | $19,423 | $7,518 | $24,279 | 27 |
| 49999 | HC UNLISTED PROCEDURE ABDOMEN PERITONEUM & OMENTUM | $24,150 | $19,320 | $1,004 | $24,150 | 27 |
| J9119 | CEMIPLIMAB-RWLC 350 MG/7ML IV SOLN | $24,020 | $19,216 | $26.83 | $24,020 | 27 |
Showing top 50 of 21,792 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.